Or register here
Global Search

Trusted Resources: Evidence & Education

Scientific literature and patient education texts

Back to Evidence & Education / Abstracts & Posters

A survey of sickle cell patients transitioned to adult care from Texas children’s hematology center between January 1999 and January 2014

key information

source: American Society of Pediatric Hematology/Oncology

year: 2016

authors: Vivien Sheehan, Anthony Wood, Sachin Allahabadi, Sara Curtis, Allexa Hammond, Ling-Chen Chien, Jaden Schupp, Matthew Rees, Peter Yeh, Kate Travis, John Shumway

summary/abstract:

An estimated 93-98% of sickle cell disease (SCD) patients now reach adulthood in high resource countries. Studies show that this growing cohort of young adult SCD patients aged 18-26 years old experiences a marked rise in medical complications and early mortality, coinciding with decreased use of life-prolonging therapies and increased use of emergency care.

Design/Method: 441 SCD patients transitioned from pediatric care at Texas Children’s Hematology Center (TCHC) between 01/1999 and 01/2014. We contacted these patients at their last known address and phone number to request completion of a 23 question survey assessing patient demographics, post-transition medical outcomes, and personal experiences.

Results: 48 surveys were completed. 17 patients (35.4%) lack a provider, with top reasons being lack of insurance/funding (44%) and “can’t find a physician” (38%). Patients without an adult physician within 6 months of transition were less likely to have a physician currently (p<0.017). 83.3% of patients on hydroxyurea as pediatric patients (15/18) continued hydroxyurea therapy after transition. Subjects reported difficulties with finding knowledgeable adult providers, medical insurance, and inadequate transition preparation. Examples of qualitative results include comments such as the following: “The adult doctors are not aware of the disease…They have to call the pediatricians.” While another said, “[It was] hard finding a physician in the two years after TCHC [because of insurance loss]… my health worsened because I wasn’t getting the medication that I needed.” When asked, 94% of patients wanted a dedicated SCD transition clinic. 12 patients were identified as deceased from all causes.

read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

© 2026 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close